Menu

Human Proteome Project Update

Researchers report steady progress in the effort to map all the proteins made by human chromosomes.

Jan 24, 2013
Bob Grant

Human monocyte chemotactic protein-2, just one of the proteins that will be mapped by the Human Proteome ProjectWIKIMEDIA, NEVIT DILMENBig science rides again with the announcement that all is well with the Chromosome-centric Human Proteome Project (C-HPP), a 10-year initiative to map all the proteins produced by genes on human chromosomes. The C-HPP was launched last year, and organizers of the effort envision a close to their activities occurring in September of 2022. The current issue of the Journal of Proteome Research is devoted entirely updating the progress of the international teams of scientists involved with the C-HPP. The highlights from the special issue include:

- An update on the effort to characterize the protein-coding genes on male-specific regions of the Y chromosome, including genetic components involved with sex determination and reversal, spermatogenesis and male infertility, prostate cancer, sex-specific effects on the brain and behavior, and graft-versus-host disease.

 

- A report from the Biology/Disease-driven Human Proteome Project (B/D-HPP), which aims to identify proteins that play pivotal roles in a variety of diseases.

 

- Recent findings from a Taiwanese group conducting a pilot study on chromosome 4, which is rich in cancer-associated proteins and could prove useful in biomarker or drug target applications. The study identifies 141 proteins on the chromosome that are “cell-secretable/shedable proteins” and an additional 54 that are classified as cancer-associated proteins.

 

- A preliminary map of the proteome of chromosome 8, which has a very high mutation rate in humans and therefore could play an important role in tumorigenesis.

 

- The announcement of a new data integration and analysis software system and browser designed specifically for the C-HPP.

The issue contains many more updates on the progress of several groups working under the auspices of the C-HPP, and the group aims to publish such a special issue for every year of the project.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.